EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Markers Mediate the Prognosis of Baseline Mismatch Volume and 90‐Day Outcomes in Acute Ischemic Stroke Patients

Lianhong Ji iD, Xinyu Xu, Peian Liu iD, Li Li iD, Jiale Gan iD, Junqi Liao, Yongxing Deng iD, Hui Jiang iD, Yunfei Han, Wenlei Li iD, Yuan Zhu iD, Minghua Wu iD

Brain and Behavior · 2026

DOI: 10.1002/brb3.71219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2026. Verfasst von Lianhong Ji und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Inflammation, Brain Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Administration of Traditional Chinese Medicine of Jiangsu Province, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While previous studies link larger ischemic penumbra volumes to worse AIS outcomes, clinical results are inconsistent. This study seeks to explore how baseline mismatch volume (a proxy for ischemic penumbra) relates to 90‐day AIS prognosis and the mediating role of inflammatory markers herein.

Methods

This study conducted a retrospective analysis of 473 patients with AIS. Logistic regression and restricted cubic spline (RCS) analysis were used to evaluate the relationship between baseline mismatch volume and poor 90‐day outcomes. The mediating role of inflammatory markers was assessed using the bootstrap method. Participants were divided into four groups based on baseline mismatch volume and outcome to further explore the role of inflammation in ischemic penumbra volume and poor outcome.

Results

Logistic regression analysis showed that baseline mismatch volume was significantly associated with poor outcomes at 90 days (OR = 1.04 [95% CI, 1.01–1.06]; p < 0.01), and RCS curve analysis showed a linear relationship between the two ( p > 0.05). Inflammatory markers partially mediated the relationship between the two (NLR: 22.9%, MLR: 17.5%, PNR: 27.4%). In addition, a small number of patients with large mismatch volumes had good outcomes, while patients with small mismatch volumes had poor outcomes, which was significantly related to the severity of their inflammatory response ( p < 0.001).

Conclusion

Larger baseline mismatch volume, higher NLR and MLR, and lower PNR were significantly associated with poor outcomes in patients with 90‐day AIS. It is worth noting that in some cases with smaller mismatch volume, patients with high NLR and MLR and low PNR still had poor outcomes. Some patients with low NLR and MLR, and high PNR still experienced favorable outcomes, even with larger mismatch volumes. These findings suggest that AIS prognosis is not solely determined by baseline mismatch volume but is also significantly influenced by systemic inflammatory responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeInflammationBrain IschemiaHumansPrognosisFemaleRetrospective StudiesMaleBiomarkersAgedMiddle Aged

Stichwörter der Autor:innen

CT perfusionacute ischemic strokeinflammatory markersmismatch volumeprognosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.

ORCID-Profile: Lianhong Ji, Peian Liu, Li Li, Jiale Gan, Yongxing Deng, Hui Jiang, Wenlei Li, Yuan Zhu, Minghua Wu

Förderung

  • Administration of Traditional Chinese Medicine of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Ji, L., Xu, X., Liu, P., Li, L., Gan, J., Liao, J., Deng, Y., Jiang, H., Han, Y., Li, W., Zhu, Y., & Wu, M. (2026). Inflammatory Markers Mediate the Prognosis of Baseline Mismatch Volume and 90‐Day Outcomes in Acute Ischemic Stroke Patients. Brain and Behavior. https://doi.org/10.1002/brb3.71219

Vancouver

Ji L, Xu X, Liu P, Li L, Gan J, Liao J, et al. Inflammatory Markers Mediate the Prognosis of Baseline Mismatch Volume and 90‐Day Outcomes in Acute Ischemic Stroke Patients. Brain and Behavior. 2026. doi:10.1002/brb3.71219

BibTeX
@article{Ji2026,
  author = {Ji, Lianhong and Xu, Xinyu and Liu, Peian and Li, Li and Gan, Jiale and Liao, Junqi and Deng, Yongxing and Jiang, Hui and Han, Yunfei and Li, Wenlei and Zhu, Yuan and Wu, Minghua},
  title = {Inflammatory Markers Mediate the Prognosis of Baseline Mismatch Volume and 90‐Day Outcomes in Acute Ischemic Stroke Patients},
  journal = {Brain and Behavior},
  year = {2026},
  doi = {10.1002/brb3.71219}
}
Kostenlos starten →